Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
PalanorPalanor

Line

Industry Clinical Trials Stopped Early

Terminated trials as a share of company-led trials that ended over the past 12 months, %

14.8% in Jun 2026the lowest in data back to 2024−2.0 pp since Jun 2024

Plays the chart through its history. Pauses are where the data set a record or moved most.

Palanor Foresight™ comes with a free Palanor account. Create one · Continuation is open to everyone.

ClinicalTrials.gov. Company-led interventional trials that ended, over the 12 months to each month; the newest three months are held back while late reports arrive.

How often companies pull the plug. Trials are stopped when the science disappoints, patients cannot be found, or money and strategy change; a rising share is an early sign of pipeline cuts.

What this chart reads

Sources

Industry Clinical Trials Stopped Early (% of Trials Ended). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

Charts are drawn from Palanor's signal library and recomputed from source data on every view. Transformations (changes, indexing, year-on-year rates) are Palanor's.

Related charts

HealthForecast

Drug Stocks Against the Market

Twenty large U.S.-listed drugmakers (by market value) and the S&P 500, price indexed to the start of the window

197.2Data yesterday
HealthForecast

U.S. Uninsured Rate

Share of people in the United States with no health insurance, annual, %

8.2%Data to Dec 2024
HealthForecast

U.S. Drug Overdose Deaths

Drug overdose deaths in the U.S., 12 months ending each month

66,478Data to May 2026
HealthForecast

FDA Novel Drug Approvals

New drugs approved by the FDA’s drug center, trailing 12 months

59Data 51 days ago
Health· StudioForecast

FDA Novel Drug Approvals, Trailing 12 Months

New molecular entities and new therapeutic biologics approved by FDA's Center for Drug Evaluation and Research.

59.0Data 51 days ago
HealthForecast

Donor Aid for Health

Bilateral aid disbursements from DAC member countries by sector, US$ billions, current prices, yearly

$7.3B1 viewsData to Dec 2024

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.